A novel zinc phthalocyanine-indometacin photosensitizer with “Three-in-one” cyclooxygenase-2-driven dual targeting and aggregation inhibition for high-efficient anticancer therapy

Photodynamic therapy, during which nontoxic photosensitizers can be photo-activated to generate cytotoxic reactive oxygen species, has attracted great interest. However, the strong aggregation and poor tumor targeting of photosensitizers, the short action radius and lifetime of reactive oxygen speci...

Full description

Saved in:
Bibliographic Details
Published in:Dyes and pigments 2022-02, Vol.198, p.109997, Article 109997
Main Authors: Huang, Kunshan, Zhang, Han, Yan, Meiqi, Xue, Jinping, Chen, Juanjuan
Format: Article
Language:English
Subjects:
Cyclooxygenase-2
Golgi apparatus
Indomethacin
Photodynamic therapy
Photosensitizer
Targeting
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Photodynamic therapy, during which nontoxic photosensitizers can be photo-activated to generate cytotoxic reactive oxygen species, has attracted great interest. However, the strong aggregation and poor tumor targeting of photosensitizers, the short action radius and lifetime of reactive oxygen species limit the therapeutic efficiency greatly. Herein, indomethacin, an inhibitor and substrate of cyclooxygenase-2, is introduced to conjugate with zinc phthalocyanines for successively solving these three problems. Own to indomethacin moiety, our designed photosensitizer IMC-Pc can bind to cyclooxygenase-2 with reduced aggregation, and its binding mechanism was demonstrated by fluorescence enhancement and docking calculations. Subsequently, the indomethacin moiety assists ZnPc selectively targeting to cyclooxygenase-2 expressive tumor cells, and further accumulating in Golgi apparatus. Importantly, our results exhibit the improved intracellular reactive oxygen species generation and enhanced anticancer efficacy of IMC-Pc. Overall, such a novel photosensitizer with “three-in-one” cyclooxygenase-2-driven dual targeting and aggregation inhibition is a promising candidate for improving therapeutic efficacy. •A cyclooxygenase-2-targeted photosensitizers was designed and synthesized.•IMC-Pc could be disaggregated by binding to COX-2 specifically.•IMC-Pc possessed tumor and golgi apparatus dual-targeted ability.•IMC-Pc could obtain enhanced anticancer activities towards cyclooxygenase-2 overexpressed monolayer cancer cells and 3D multicellular tumor spheroidsand.
ISSN:0143-7208
1873-3743
DOI:10.1016/j.dyepig.2021.109997